Federal contract award
15B31525F00000006
PHARMACY TECH, PHLEBOTOMIST, AND RADIOLOGICAL TECHNOLOGIST SERVICES FCC YAZOO CITY, PERIOD OF PERFORMANCE: OCT. 1 - 31, 2024 (CR) BPA#15B31521A00000057 FSS#V797D-50384
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Justice |
| Office | FCC YAZOO CITY |
| NAICS | 561320 — Temporary Help Services |
| PSC | Q999 — Other Medical Services |
| Parent award / vehicle | 15B31521A00000057 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $89.4K |
| Current contract value | $89.4K |
| Potential contract value / ceiling | $89.4K |
| Start date | Oct 1, 2024 |
| Current end date | Sep 30, 2025 |
| Potential end date | Sep 30, 2025 |
| Latest award activity | Apr 7, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Apr 7, 2025 | P00003 | $-22.7K | THIS MODIFICATION TO 15B31525F00000006 WILL DECREASE CLIN 0001 BY 174 SS, CLIN 0002 BY 268.5 SS AND CLIN 0003 BY 273.25 SS TOTALING $22,732.24. THE TOTAL AMOUNT OF THIS BPC WILL BE $89,422.16. |
| Dec 23, 2024 | P00002 | $40.6K | THIS MODIFICATION TO 15B31525F00000006 WILL INCREASE CLIN 0001 BY 180 SS, CLIN 0002 BY 540 SS AND CLIN 0003 BY 540 SS TOTALING $40,557.60. THE TOTAL AMOUNT OF THIS BPC WILL BE $112,154.40. |
| Nov 26, 2024 | P00001 | $40.6K | THIS MODIFICATION TO 15B31525F00000006 WILL INCREASE CLIN 0001 BY 180, CLIN 0002 BY 540 SS AND CLIN 0003 BY 540 SS TOTALING $40,557.60. THE TOTAL AMOUNT OF THIS BPC WILL BE $71,596.80. |
| Oct 29, 2024 | 0 | $31.0K | PHARMACY TECH, PHLEBOTOMIST, AND RADIOLOGICAL TECHNOLOGIST SERVICES FCC YAZOO CITY, PERIOD OF PERFORMANCE: OCT. 1 - 31, 2024 (CR) BPA#15B31521A00000057 FSS#V797D-50384 |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.